Private Equity M&A Activity in Healthcare Rises in Q2:24
Private equity (PE) investment has continued to play a substantial role in the healthcare M&A market. In the second quarter of 2024, there were 186 deals completed by PE companies or their sponsored companies (PE buyers, collectively), or approximately 38% of all the 496 announced healthcare deals, according to new data captured in the LevinPro HC database. This is a 24% increase from the first quarter of 2024 when 150 acquisitions from PE buyers were announced. Activity in Q2:24 represents a 17% decrease from Q2:23 when 224 PE buyer transactions were reported. In Q2:24, 10 transactions with a PE buyer had a disclosed price. The ten deals totaled more than $5.49 billion in announced... Read More »
Healthcare M&A Volume Drops in Q2:24, According to Acquisition Data from LevinPro HC
Healthcare merger and acquisition activity slightly decreased in the second quarter of 2024, with 496 deals announced, according to new acquisition data from LevinPro HC. Activity in the Q2:24 was 2% lower than in the first quarter, when 506 transactions were announced. However, it is a drop of 18% compared with activity in the second quarter of 2023, when 604 deals were announced. Activity in sectors such as Physician Medical Groups and Other Services drove much of the volume, with 124 and 135 deals, respectively. Demand for healthcare real estate, such as medical outpatient buildings and properties, has driven high deal volume in the Other Services for the past several years. Activity in... Read More »
Unraveling Healthcare Real Estate in 2024: A Conversation with Christopher Stai of HREA Healthcare Real Estate Advisors
The Real Estate Investment Firm (REIF) and Real Estate Investment Trust (REIT) markets remain among the most dynamic sectors. The first half of 2024 (1H 2024) exemplified this trend, continuing to demonstrate significant activity and engagement. The REIF sector has shown significant acquisition activity in acquisitions in the past few years. In 2019, there were two transactions with a REIF buyer. This jumped to 22 transactions in 2020, 74 deals in 2021, and continued to escalate in 2022 when 141 transactions were announced. Yet, there was a decline in 2023 when 97 acquisitions were announced. In the first six months of 2024, 52 transactions were completed by a REIF buyer. We spoke with... Read More »
Substance Use Disorder M&A Market During 1H 2024
The substance use disorder (SUD) specialty is often the most active submarket in the Behavioral Health Care (BHC) sector, and the first half of 2024 was no exception. According to data captured in the LevinPro HC database, 10 SUD deals were announced during the first six months of 2024, making up about 28% of all BHC deals announced during that time. 1H 2024 activity mirrored the activity witnessed in the first half of 2023, when SUD deals comprised 27% of all BHC deals announced. This consistency reflects sustained investor interest in the SUD treatment space. However, a comparison to the first half of 2022 (36% of BHC deals) and 2021 (34% of BHC deals), when SUD deal totals hit 21... Read More »
Are We Past the Healthcare Retail Peak?
The Pull-Back Strategy of Village MD The March 2024 announcement from Walgreens Boots Alliance to scale back nearly half of its VillageMD clinics has sent shockwaves through the retail healthcare field. This pull-back, coupled with similar moves by Walmart and hints of caution from other retailers like CVS Health, raises serious questions about the long-term viability of the entire model. When we first covered the retail healthcare space back in late 2022, the message from many industry experts was that retail healthcare was here to stay. But now, with the recent news of Walgreens planning to close 160 VillageMD clinics across several states, we can’t help but to wonder – has retail... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
